Developed by DRDO, 2-DG has been granted permission by DCGI for emergency use as adjunct therapy in moderate to severe COVID-19 patients.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.